Source comparison
BPC-157 for Stomach Ulcers Research: Rodent vs Human Comparison
Healing Timeframe 24–72 hours show measurable improvement Typical ulcer healing requires 4–8 weeks Accelerated rodent metabolism and healing kinetics don't directly translate. Human dosing and duration unknown Primary Evidence Base 40+ published preclinical st
This comparison does not assign a generated winner or score.
- Healing Timeframe
- 24–72 hours show measurable improvement
- Typical ulcer healing requires 4–8 weeks
- Accelerated rodent metabolism and healing kinetics don't directly translate. Human dosing and duration unknown
- Primary Evidence Base
- 40+ published preclinical studies across multiple injury models
- Zero registered Phase II/III trials in indexed databases
- Evidence hierarchy insufficient for clinical recommendation despite mechanistic plausibility
- Dosing Protocol
- 10 mcg/kg body weight effective in majority of studies
- No established human therapeutic dose
- Scaling from rodent models requires allometric adjustment plus safety validation
- Administration Route
- Intraperitoneal or intragastric in research models
- Oral bioavailability in gastric pH environment unvalidated
- Peptide degradation by pepsin and low pH represents significant delivery challenge
- Mechanism Validation
- VEGF upregulation, NO modulation, cytokine shift documented
- Mechanism assumed conserved but unconfirmed in human gastric tissue
- Cross-species mechanism conservation likely but requires direct human tissue studies
- Safety Profile
- No acute toxicity observed at therapeutic doses in rodent studies
- Human safety data essentially non-existent beyond anecdotal self-experimentation
- Absence of controlled safety trials means adverse event profile unknown